Cruz, Cita S.
HRN: 26-63-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2025
ACICLOVIR 800MG (TAB)
02/05/2025
02/11/2025
PO
800mg
BID
Herpes Zoster
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes